Search results for "Thromboprophylaxis"
Reducing HIT by removing the culprit
An “avoid heparin” policy yields benefit.
https://acphospitalist.acponline.org/archives/2017/02/success-story-heparin-induced-thrombocytopenia.htm
15 Feb 2017
Inpatient mortality from major bleeds lower in patients on DOACs than warfarin
Intracranial hemorrhages, especially subdural hematomas, comprised a higher proportion of major bleeding in patients on warfarin, while those on direct oral anticoagulants (DOACs) had a higher proportion of gastrointestinal bleeds.
https://acphospitalist.acponline.org/weekly/archives/2017/03/08/4.htm
8 Mar 2017
Virtual glucose monitoring, statins and heart surgery
Summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2017/08/recent-research.htm
15 Aug 2017
Enoxaparin and dalteparin similarly effective for VTE prophylaxis in trauma patients
In a U.S. hospital, the low-molecular-weight heparin on the formulary was switched from enoxaparin to dalteparin and then back to enoxaparin, and venous thromboembolism (VTE) rates were compared under these policies.
https://acphospitalist.acponline.org/weekly/archives/2017/08/30/1.htm
30 Aug 2017
MI performance measures, health literacy and LOS, and more
Summaries from ACP Hospitalist Weekly.
https://acphospitalist.acponline.org/archives/2018/02/recent-research.htm
15 Feb 2018
Spontaneous HIT syndrome
A review explains an unusual case of heparin-induced thrombocytopenia.
https://acphospitalist.acponline.org/archives/2018/05/spontaneous-heparin-induced-thrombocytopenia-syndrome.htm
15 May 2018
Rivaroxaban at discharge did not significantly reduce deaths due to VTE, study finds
Patients who were randomized to 45 days of rivaroxaban instead of placebo did have lower risk of nonfatal venous thromboembolism (VTE), the industry-funded trial found.
https://acphospitalist.acponline.org/weekly/archives/2018/08/29/1.htm
29 Aug 2018
Compression stockings may be unnecessary for VTE prophylaxis in most patients undergoing elective surgery
In a randomized controlled trial of patients at moderate or high risk of venous thromboembolism (VTE), prophylaxis with low-molecular-weight heparin alone was noninferior to a combination of low-molecular-weight heparin and graduated compression stockings.
https://acphospitalist.acponline.org/weekly/archives/2020/05/20/5.htm
20 May 2020
Guidelines, studies make recommendations on VTE prophylaxis for inpatients with COVID-19
A new CHEST guideline supports standard-dose anticoagulant thromboprophylaxis, while authors of two recent studies of hypercoagulability called for higher doses.
https://acphospitalist.acponline.org/weekly/archives/2020/06/10/2.htm
10 Jun 2020
Rivaroxaban after discharge may reduce thromboembolic risk in medically ill
An industry-funded trial that gave medical patients rivaroxaban for 45 days after hospital discharge found decreased risk for a composite end point of symptomatic venous thromboembolism, myocardial infarction, nonhemorrhagic stroke, and cardiovascular death compared to placebo.
https://acphospitalist.acponline.org/weekly/archives/2020/06/24/3.htm
24 Jun 2020